IVIVR establishment and BE predictions
In Silico trial to establish a IVIVR model based on Bioequivalence outcome
In Silico trial to establish a IVIVR model based on Bioequivalence outcome
PK sparse sampling scheme optimization for phase III clinical trial in Oncology
The Sponsor intended to have a bio-predictive media followed by IVIVR model to predict the plasma exposure for different in-vitro release and different doses. The
Enhancing the efficacy of a COVID-19 Vaccine
In silico MD clinical trial in children 12-18 years of age
The Sponsor intended to have a “dissolution safe space” based on the bio batch dissolution specifications. The Sponsor had performed a BA BE study and
Augmenting Tuberculosis clinical trials with a Synthetic Arm
In Silico trial to optimize formulation composition of transdermal patch for achieving bioequivalence
In Silico trial to replace Bioequivalence trial for formulation with different particle size distribution (PSD)
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved